Drug Shortage Report for CLADRIBINE INJECTION
Report ID | 212507 |
Drug Identification Number | 02319918 |
Brand name | CLADRIBINE INJECTION |
Common or Proper name | CLADRIBINE INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CLADRIBINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-01 |
Actual start date | 2024-01-01 |
Estimated end date | 2024-04-14 |
Actual end date | 2024-04-05 |
Shortage status | Resolved |
Updated date | 2024-04-06 |
Company comments | Due to production delays, we will be facing a supply interruption effective January 1, 2024 until April 14, 2024. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-12-05 | English | Compare |
v2 | 2023-12-05 | French | Compare |
v3 | 2024-01-02 | English | Compare |
v4 | 2024-01-31 | English | Compare |
v5 | 2024-01-31 | French | Compare |
v6 | 2024-03-08 | English | Compare |
v7 | 2024-03-08 | French | Compare |
v8 | 2024-04-05 | English | Compare |
v9 | 2024-04-05 | French | Compare |
v10 | 2024-04-06 | English | Compare |
Showing 1 to 10 of 10